Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 772,219 |
|
|||||
| News | - | ||||||
| Day High | 15.06 | Low High |
|||||
| Day Low | 14.705 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.21 | 1.43% | 14.89 | 18:18:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.84 | 14.705 | 15.06 | 14.89 | 14.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,051 | 772,219 | $ 14.90 | $ 11,503,199 | - | 11.09 - 17.765 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:29:24 | 1 | $ 15.15 | USD |
Catalyst Pharmaceuticals (CPRX) Options Flow Summary
Catalyst Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.75B | 117.86M | - | 398.2M | 71.41M | 0.61 | 24.56 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.34 | 15.80 | 14.585 | 15.05 | 2,259,151 | -0.45 | -2.93% |
| 1 Month | 15.79 | 16.25 | 14.585 | 15.32 | 1,342,330 | -0.90 | -5.70% |
| 3 Months | 14.425 | 17.495 | 13.1161 | 15.32 | 1,364,027 | 0.465 | 3.22% |
| 6 Months | 12.98 | 17.495 | 11.89 | 14.77 | 1,410,663 | 1.91 | 14.71% |
| 1 Year | 16.13 | 17.765 | 11.09 | 13.98 | 1,482,594 | -1.24 | -7.69% |
| 3 Years | 4.58 | 22.11 | 4.43 | 12.38 | 1,615,280 | 10.31 | 225.11% |
| 5 Years | 6.01 | 22.11 | 2.235 | 8.68 | 1,765,541 | 8.88 | 147.75% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. |
